Normal pressure hydrocephalus (NPH) is a brain disorder that mimics dementia but is sometimes reversible with surgery, which is why families should not assume every case of memory loss and unsteady walking is Alzheimer's. NPH is a syndrome of enlarged brain ventricles with normal cerebrospinal fluid (CSF) pressure, and per StatPearls it produces a classic triad: gait trouble, cognitive decline, and urinary incontinence. The difference matters because NPH can be treated at its source, while most dementias cannot. Recognizing it early gives some patients a real chance to walk, think, and function better again.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What NPH is and how it differs from dementia
- How common is NPH, and who gets it?
- How doctors tell NPH apart
- What treatment looks like and how well it works
- Why timing and coexisting conditions matter
- Frequently Asked Questions
What NPH is and how it differs from dementia
Cerebrospinal fluid normally cushions the brain and drains away on a steady cycle. In NPH, fluid builds up in the brain's ventricles even though a pressure test looks normal, stretching nearby tissue and disrupting how the brain controls movement, thinking, and bladder function. The tell is the pattern.
In typical Alzheimer's dementia, memory loss usually comes first. In NPH, walking problems often lead the way — a slow, wide, "stuck to the floor" shuffle — followed by trouble with attention and planning, and later bladder urgency or leaks. That gait-first pattern is a useful flag for families. It does not confirm NPH by itself, but it is a reason to ask a doctor specifically about hydrocephalus rather than accepting a general dementia label.
How common is NPH, and who gets it?
NPH is a disorder of older age. A prospective population-based study reported by Andersson and colleagues found idiopathic NPH in about 3.7% of people aged 65 and older, rising to 8.9% at age 80 and above, compared with 2.1% between ages 65 and 79. Those numbers mean NPH is not rare among the oldest adults — roughly one in eleven people past 80 in that study.
Yet it is routinely overlooked. The condition is often misread as Alzheimer's or Parkinson's disease. A review in PMC notes that the Hydrocephalus Association estimates about 80% of NPH cases go unrecognized, so many treatable patients never get evaluated.
How doctors tell NPH apart
Diagnosis leans heavily on brain imaging combined with the symptom pattern. On mri or CT, NPH shows enlarged ventricles with a narrowed callosal angle — measurable features that, according to the same PMC review, help separate NPH from the shrinking, or atrophy, seen in Alzheimer's disease. Doctors may also drain a modest amount of spinal fluid through a lumbar puncture, sometimes called a tap test, and then re-check walking and thinking.
Clear improvement afterward suggests the person may respond to surgery. No single test is perfect, so specialists weigh imaging, the tap test, and symptom history together. This is work for a neurologist or neurosurgeon familiar with NPH, not a diagnosis to make from symptoms alone.
What treatment looks like and how well it works
The main treatment is surgical, not a pill. Surgeons place a ventriculoperitoneal shunt — a thin tube that drains excess CSF from the brain to the abdomen, where the body absorbs it. A single-center study in PMC reports that walking, cognition, and quality of life improve significantly by roughly three months after surgery.
Larger data are encouraging. In a multicenter prospective study by Giordan and colleagues, 91.2% of shunted patients improved at 12 months, with a complication rate of 8.8% and a reoperation rate of 9.4%. Those complication figures are real and worth discussing frankly with the surgical team. A shunt is a lasting implant that can need adjustment or a second operation, so the decision balances likely benefit against surgical risk.
Why timing and coexisting conditions matter
Waiting carries a cost. According to Medscape, shunt outcomes worsen as the disease advances, and shorter symptom duration — for example under six months — plus a gait-predominant onset predict better recovery. That makes early evaluation genuinely urgent.
NPH also does not always travel alone. Research by Leinonen and colleagues found many clinical-NPH patients had coexisting Alzheimer's pathology on brain biopsy, which correlated with a poorer shunt response. NPH and dementia can exist in the same person, so a shunt may help symptoms without curing everything. If you suspect NPH, a few practical steps help: Act sooner rather than later; the same features that make NPH treatable also fade the longer symptoms go unaddressed.
- Note whether unsteady walking appeared before, not after, memory problems.
- Ask the doctor directly whether NPH has been ruled out with imaging.
- Request referral to a neurologist or neurosurgeon experienced with NPH.
- Ask about a tap test before assuming surgery will or won't help.
- Use the Hydrocephalus Association's NPH guide and clinician finder to locate specialists.
Frequently Asked Questions
Can a shunt cure dementia?
No. A shunt treats NPH, not Alzheimer's or other degenerative dementias. If both are present, it may ease some symptoms without stopping the underlying dementia.
What is the first symptom families usually notice in NPH?
Often a slow, wide, shuffling walk that appears before clear memory loss. That gait-first pattern is a reason to ask specifically about NPH.
Is the surgery risky?
There is real risk. In one multicenter study the complication rate was 8.8% and about 9.4% of patients needed a repeat operation, so discuss the trade-offs with the surgical team.
